Literature DB >> 282646

Histamine H1 receptors identified in mammalian brain membranes with [3H]mepyramine.

V T Tran, R S Chang, S H Snyder.   

Abstract

The antihistamine [3H]mepyramine binds to H1 histamine receptors in mammalian brain membranes. Potencies of H1 antihistamines at the binding sites correlate with their pharmacological antihistamine effects in the guinea pig ileum. Specific [3H]mepyramine binding is saturable with a dissociation constant of about 4 nM in both equilibrium and kinetic experiments and a density of 10 pmol per gram of whole kinetic experiments and a density of 10 pmol per gram of whole brain. Some tricyclic antidepressants are potent inhibitors of specific [3H]mepyramine binding. Regional variations of [3H]mepyramine binding do not correlate with variations in endogeneous histamine and histidine decarboxylase activity.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 282646      PMCID: PMC393167          DOI: 10.1073/pnas.75.12.6290

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  15 in total

1.  Some chemical and physical properties associated with histamine antagonism.

Authors:  P B MARSHALL
Journal:  Br J Pharmacol Chemother       Date:  1955-09

Review 2.  Histaminergic mechanisms in brain.

Authors:  J C Schwartz
Journal:  Annu Rev Pharmacol Toxicol       Date:  1977       Impact factor: 13.820

3.  Kinetics of blockade of different receptors by chlorpromazine in rabbit stomach strips.

Authors:  R R Ruffolo; P N Patil
Journal:  Eur J Pharmacol       Date:  1978-03-15       Impact factor: 4.432

4.  Tricyclic antidepressant drugs block histamine H2 receptor in brain.

Authors:  J P Green; S Maayani
Journal:  Nature       Date:  1977-09-08       Impact factor: 49.962

5.  Tricyclic antidepressants block histamine H1 receptors of mouse neuroblastoma cells.

Authors:  E Richelson
Journal:  Nature       Date:  1978-07-13       Impact factor: 49.962

6.  Inhibition of the uptake of tritiated catecholamines by antidepressant and related agents.

Authors:  S B Ross; A L Renyi
Journal:  Eur J Pharmacol       Date:  1967-12       Impact factor: 4.432

7.  Histamine H1-receptors in brain labeled with 3H-mepyramine.

Authors:  R S Chang; V T Tran; S H Snyder
Journal:  Eur J Pharmacol       Date:  1978-04-15       Impact factor: 4.432

8.  Brain histamine receptors as targets for antidepressant drugs.

Authors:  P D Kanof; P Greengard
Journal:  Nature       Date:  1978-03-23       Impact factor: 49.962

9.  The binding of conformationally restricted antihistamines to histamine receptors.

Authors:  R R Ison; F M Franks; K S Soh
Journal:  J Pharm Pharmacol       Date:  1973-11       Impact factor: 3.765

10.  Specific binding of 3H-mepyramine to histamine H1 receptors in intestinal smooth muscle.

Authors:  S J Hill; J M Young; D H Marrian
Journal:  Nature       Date:  1977-11-24       Impact factor: 49.962

View more
  37 in total

1.  Relationship between sedation and pupillary function: comparison of diazepam and diphenhydramine.

Authors:  Ruihua H Hou; Jessica Scaife; Clare Freeman; Rob W Langley; Elemer Szabadi; Chris M Bradshaw
Journal:  Br J Clin Pharmacol       Date:  2006-06       Impact factor: 4.335

2.  Interactions of isamoltane (CGP 361A), an anxiolytic phenoxypropanolamine derivative, with 5-HT1 receptor subtypes in the rat brain.

Authors:  P C Waldmeier; M Williams; P A Baumann; S Bischoff; M A Sills; R F Neale
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-06       Impact factor: 3.000

3.  Profile of in vitro binding affinities of neuroleptics at different rat brain receptors: cluster analysis comparison with pharmacological and clinical profiles.

Authors:  R Testa; G Abbiati; R Ceserani; G Restelli; A Vanasia; D Barone; M Gobbi; T Mennini
Journal:  Pharm Res       Date:  1989-07       Impact factor: 4.200

Review 4.  Monoamine reuptake inhibitors in Parkinson's disease.

Authors:  Philippe Huot; Susan H Fox; Jonathan M Brotchie
Journal:  Parkinsons Dis       Date:  2015-02-25

5.  Additional data on the function of hypothalamic histamine.

Authors:  Z Huszti
Journal:  Agents Actions       Date:  1981-04

6.  Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II.

Authors:  Shu-Feng Zhou
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

7.  The binding of doxepin to histamine H1-receptors in guinea-pig and rat brain.

Authors:  J Aceves; S Mariscal; K E Morrison; J M Young
Journal:  Br J Pharmacol       Date:  1985-02       Impact factor: 8.739

8.  Regulatory influence of histamine receptor activation and inhibition on the synthesis and level of hypothalamic histamine.

Authors:  Z Huszti; K Magyar
Journal:  Agents Actions       Date:  1984-06

9.  Histamine H1-agonist potentiation of adenosine-stimulated cyclic AMP accumulation in slices of guinea-pig cerebral cortex: comparison of response and binding parameters.

Authors:  P R Daum; S J Hill; J M Young
Journal:  Br J Pharmacol       Date:  1982-10       Impact factor: 8.739

10.  Evaluation of the CNS properties of SCH 29851, a potential non-sedating antihistamine.

Authors:  A Barnett; L C Iorio; W Kreutner; S Tozzi; H S Ahn; A Gulbenkian
Journal:  Agents Actions       Date:  1984-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.